Features

A new program launched by Yeda, the Weizmann Institute’s technology transfer arm, is bridging the gap between basic science breakthroughs and commercial application.

The Nancy and Stephen Grand Israel National Center for Personalized Medicine is bench-to-bedside at its best, advancing insights from basic research and working with hospitals and physicians throughout Israel to turn knowledge into therapies that will benefit human health.

The Weizmann Institute of Science is establishing the Dr. Barry Sherman Institute for Medicinal Chemistry thanks to a major gift from the Sherman family of Toronto. It will fund innovative research on compounds that hold promise for becoming therapies for a range of diseases.